View in EDS HTML Full Text PDF Full Text

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

Saved in:

Bibliographic Details
Title:	Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.
Authors:	Hatanaka, Takeshi¹ (AUTHOR), Yata, Yutaka² (AUTHOR) yu‐yata@maebashi.saiseikai.or.jp, Hiraoka, Atsushi³ (AUTHOR), Tada, Toshifumi⁴ (AUTHOR), Hirooka, Masashi⁵ (AUTHOR), Kariyama, Kazuya⁶ (AUTHOR), Tani, Joji⁷ (AUTHOR), Atsukawa, Masanori⁸ (AUTHOR), Takaguchi, Koichi⁹ (AUTHOR), Itobayashi, Ei¹⁰ (AUTHOR), Kakizaki, Satoru^11,12 (AUTHOR), Fukunishi, Shinya¹³ (AUTHOR), Tsuji, Kunihiko¹⁴ (AUTHOR), Ishikawa, Toru¹⁵ (AUTHOR), Tajiri, Kazuto¹⁶ (AUTHOR), Toyoda, Hidenori¹⁷ (AUTHOR), Koshiyama, Yuichi¹⁷ (AUTHOR), Ogawa, Chikara¹⁸ (AUTHOR), Nishikawa, Hiroki¹⁹ (AUTHOR), Nishimura, Takashi¹³ (AUTHOR)
Source:	Liver International. Jul2025, Vol. 45 Issue 7, p1-8. 8p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!